Inactive Instrument

News Kane Biotech Inc Toronto S.E.

Equities

KNE

CA4838092084

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Transcript : Kane Biotech Inc. - Special Call	Apr. 18
Kane Biotech to Host Investor Webinar	Apr. 16	GL
Kane Biotech Up 12% After Reporting Closing of STEM Animal Health Sale	Apr. 15	MT
Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products	Apr. 15	GL
Dechra Veterinary Products, Inc. completed the acquisition of 66.66% stake in STEM Animal Health Inc. from Kane Biotech Inc..	Apr. 14	CI
Kane Biotech Agrees to Sell its Interest in STEM Animal Health for US$8 Million	Apr. 11	MT
Canadian Investment Regulatory Organization Trade Resumption - KNE	Apr. 11	AQ
Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health	Apr. 11	GL
Canadian Investment Regulatory Organization Trading Halt - KNE	Apr. 11	AQ
Transcript : Kane Biotech Inc., Q4 2023 Earnings Call, Mar 26, 2024	Mar. 26
Kane Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Kane Biotech Brief: Says otal revenue for the three months ended December 31, 2023 was $764,997	Mar. 26	MT
Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results	Mar. 26	GL
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health	Mar. 20	MT
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health	Mar. 20	GL
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow	Mar. 19	GL
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow	Mar. 19	AQ
Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award	Mar. 08	GL
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair	Feb. 22	GL
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair	Feb. 22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kane Biotech Inc Toronto S.E.

Equities

KNE

CA4838092084

Summary

Filters